My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 11 711 / DOI: 10.3332/ecancer.2017.711

Research

The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance

Active surveillance (AS) is a considered treatment option for men with low or very low-risk prostate cancer. However, on repeat biopsy some 25% were upgraded and recommended for active treatment. We compare the presence or absence of primary circulating prostate cells (CPCs) with the clinical pathological findings after radical prostatectomy in men fulfilling the criteria for active surveillance and the risk of reclassification for active observation (AO).

Methods and patients: A single centre observational study was done involving 102 men who fulfilled the Epstein criteria for AS and underwent radical prostatectomy as mono-therapy for prostate cancer. The patients were classified according to the presence or absence of CPCs detected immediately before the prostate biopsy. Mononuclear cells were obtained by differential gel centrifugation of 8 mL of venous blood and CPCs identified using immunocytochemistry with anti-PSA and anti-P504S. A positive CPC test was defined as at least 1 PSA ( ), P504S ( ) cell detected/blood sample. The surgical specimen was analysed for Gleason score and pathological stage.

Results: A total of 25 out of 102 (24.5%) men were upgraded based on the pathological findings of the surgical specimen. Among which 45 (44%) men were positive for CPCs. They were younger, 63.9 versus 68.1 years (p = 0.0148), had a lower frequency of pT2 or lower disease (64.4% versus 91.2% p <0.001), higher median Gleason scores (6 versus 5 p < 0.001) in both the biopsy and surgical specimens, and a higher frequency of upgrading 44% versus 9% (p < 0.001).

Conclusions: In men fulfilling the criteria for AS, the presence of primary CPCs suggests a high risk for disease upgrade and therefore these men may not be ideal for observational therapy. Further studies with a larger population are warranted.

Keywords: prostate cancer; active surveillance; circulating prostate cells

Loading Article Metrics ... Please wait

Related articles

Review: Gastric cancer and related epigenetic alterations

Abstract | Full Article | PDF Published: 17 Jan 2017 / DOI: 10.3332/ecancer.2017.714

Research: Estimation of life expectancy of patients diagnosed with the most common cancers in the Valparaiso Region, Chile

Abstract | Full Article | PDF Published: 17 Jan 2017 / DOI: 10.3332/ecancer.2017.713

Special Issue: Hepatocellular carcinoma in identical twins in Chile: case report

Abstract | Full Article | PDF | Spanish Published: 21 Dec 2016 / DOI: 10.3332/ecancer.2016.708

Special Issue: Central nervous system metastasis secondary to colorectal cancer: a retrospective cohort study of 20 cases

Abstract | Full Article | PDF | Spanish Published: 21 Dec 2016 / DOI: 10.3332/ecancer.2016.705

Conference Report: Biomarkers come of age: PD1 in the frontline and cell cycle therapy swells the ranks of personalised therapy in the European Society of Medical Oncology (ESMO) congress, Copenhagen, 7–10 October 2016

Abstract | Full Article | PDF Published: 16 Dec 2016 / DOI: 10.3332/ecancer.2016.703



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence